Skip to main content
Premium Trial:

Request an Annual Quote

A Bad Shuffle

Premium

Researchers at Children's Hospital Boston and at Harvard's Immune Disease Institute have created a method to identify possible break points in the genome where chromosomes are susceptible to break and recombine, according to a Children's Hospital press release. A deep understanding of where and when chromosomes are likely to break could advance researchers' knowledge of cancer genomics and help guide the development of gene therapy-based treatments for a number of diseases, the press release adds. When chromosomes break, they are sometimes rearranged, and these translocations can sometimes form new fusion genes that can lead to cancer. The study, published in Cell, elucidates the mechanisms behind this chromosomal shuffling, the researchers say. The team's mapping method for the "translocatome" — what they're calling the genome-wide effects of these translocations — is called "high-throughput genome-wide translocation sequencing," the hospital says, and "is based on the action of DNA-cutting enzymes such as I-SceI, a general type of enzyme that is also under scrutiny as a possible gene therapy tool." The researchers found that the broken pieces of the chromosome tend to fuse near the beginning of genes with high frequency, and that the fragments tend to rearrange themselves within the same chromosome instead of sharing pieces across different chromosomes. "This greater understanding of where and the rules by which translocations occur could lead to a new way of thinking about how particular genes and translocations contribute to cancer," the press release says. "For instance, HTGTS could help scientists figure out which oncogenes might contribute to different tumors by showing which have a high potential for containing translocation sites in tumor progenitors." This could be particularly useful for childhood cancers like leukemia or lymphoma, in which translocations tend to be more common.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.